AprilBio Co.,Ltd. (397030.KQ)
- Previous Close
15,400.00 - Open
15,800.00 - Bid 15,680.00 x --
- Ask 15,690.00 x --
- Day's Range
15,360.00 - 15,850.00 - 52 Week Range
11,980.00 - 25,900.00 - Volume
91,500 - Avg. Volume
299,415 - Market Cap (intraday)
343.878B - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
35,000.00
AprilBio Co., Ltd. develops long-acting type biobetter and antibody biologics. The company develops products based on its long-acting protein medicine platform technology. It is developing various products for use in the treatment of rare diseases, cancer, male infertility, autoimmune and inflammatory diseases. The company was founded in 2013 and is headquartered in Chuncheon-si, South Korea.
www.aprilbio.comRecent News: 397030.KQ
View MorePerformance Overview: 397030.KQ
Trailing total returns as of 4/23/2025, which may include dividends or other distributions. Benchmark is KOSPI Composite Index (^KS11) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 397030.KQ
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 397030.KQ
View MoreValuation Measures
Market Cap
337.52B
Enterprise Value
246.15B
Trailing P/E
16.87
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
12.26
Price/Book (mrq)
3.71
Enterprise Value/Revenue
8.95
Enterprise Value/EBITDA
11.12
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
--
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
--
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--